Literature DB >> 2453290

Antisense RNA inhibits expression of membrane skeleton protein 4.1 during embryonic development of Xenopus.

D H Giebelhaus1, D W Eib, R T Moon.   

Abstract

Plasmids expressing partial-length sense or antisense protein 4.1 RNA were microinjected into fertilized Xenopus eggs. Nuclease protection assays reveal that antisense protein 4.1 RNA lead to the specific loss of endogenous protein 4.1 transcripts after midblastula transition, with no effect on the levels of three unrelated transcripts. As a control, we show that this dramatic loss of endogenous protein 4.1 transcripts is blocked when fertilized eggs receive a second injection of plasmids that express partial-length sense protein 4.1 RNA. Immunocytochemistry of tadpole embryos with antibodies monospecific for protein 4.1 demonstrates that the antisense protein 4.1 RNA blocks the normal expression of protein 4.1 in embryos and interferes with the normal interdigitation of the photoreceptor outer segments with the pigment epithelium layer in the retina. These data suggest that reduced expression of a single membrane skeleton protein is sufficient to perturb normal cellular interactions of the retina.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453290     DOI: 10.1016/0092-8674(88)90576-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  14 in total

1.  Transgenic Xenopus laevis tadpoles: a transient in vivo model system for the manipulation of lens function and lens development.

Authors:  R H Brakenhoff; R C Ruuls; E H Jacobs; J G Schoenmakers; N H Lubsen
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

Review 2.  Xenopus transcription factors: key molecules in the developmental regulation of differential gene expression.

Authors:  A P Wolffe
Journal:  Biochem J       Date:  1991-09-01       Impact factor: 3.857

3.  Retrovirol gene transfer in Xenopus cell lines and embryos.

Authors:  J C Burns; L McNeill; C Shimizu; T Matsubara; J K Yee; T Friedmann; B Kurdi-Haidar; E Maliwat; C E Holt
Journal:  In Vitro Cell Dev Biol Anim       Date:  1996-02       Impact factor: 2.416

Review 4.  Role of tissue specific alternative pre-mRNA splicing in the differentiation of the erythrocyte membrane.

Authors:  E J Benz; S C Huang
Journal:  Trans Am Clin Climatol Assoc       Date:  1997

5.  Temporally uncontrolled expression of linearized plasmid DNA which carries bacterial chloramphenicol acetyltransferase gene withXenopus cardiacα-actin promoter after injection intoXenopus fertilized eggs.

Authors:  Koichiro Shiokawa; Yuchang Fu; Keiichi Hosokawa; K Yamana
Journal:  Rouxs Arch Dev Biol       Date:  1990-11

6.  Isolation of the Xenopus homolog of int-1/wingless and expression during neurula stages of early development.

Authors:  J Noordermeer; F Meijlink; P Verrijzer; F Rijsewijk; O Destrée
Journal:  Nucleic Acids Res       Date:  1989-01-11       Impact factor: 16.971

7.  The conditional inhibition of gene expression in cultured Drosophila cells by antisense RNA.

Authors:  T A Bunch; L S Goldstein
Journal:  Nucleic Acids Res       Date:  1989-12-11       Impact factor: 16.971

8.  Drosophila coracle, a member of the protein 4.1 superfamily, has essential structural functions in the septate junctions and developmental functions in embryonic and adult epithelial cells.

Authors:  R S Lamb; R E Ward; L Schweizer; R G Fehon
Journal:  Mol Biol Cell       Date:  1998-12       Impact factor: 4.138

9.  Protein 4.1 deficiency associated with an altered binding to the spectrin-actin complex of the red cell membrane skeleton.

Authors:  F Lorenzo; N Dalla Venezia; L Morlé; F Baklouti; N Alloisio; M T Ducluzeau; L Roda; P Lefrançois; J Delaunay
Journal:  J Clin Invest       Date:  1994-10       Impact factor: 14.808

10.  Expression of the poly(A)-binding protein during development of Xenopus laevis.

Authors:  B D Zelus; D H Giebelhaus; D W Eib; K A Kenner; R T Moon
Journal:  Mol Cell Biol       Date:  1989-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.